Company profile for Anchen Pharmaceutical, Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Par Pharmaceutical and its team of dedicated healthcare professionals bring new, high-quality products to market that are the therapeutic equivalent of the brand-name pharmaceuticals. Our generic drug portfolio consists of numerous products across a wide range of therapeutic areas. We are focused on niche, high-barrier-to-entry products that have limited competition and long life cycles. Founded in 1978, today the #5 ranked...
Par Pharmaceutical and its team of dedicated healthcare professionals bring new, high-quality products to market that are the therapeutic equivalent of the brand-name pharmaceuticals. Our generic drug portfolio consists of numerous products across a wide range of therapeutic areas. We are focused on niche, high-barrier-to-entry products that have limited competition and long life cycles. Founded in 1978, today the #5 ranked US generic company.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
300 Tice BoulevardWoodcliff Lake, NJ 07677, USA
Telephone
Telephone
(201) 802 4000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmacompass.com/pdf/news/janumet-xr-metformin-hcl-sitagliptin-phosphate-merck-v-anchen-pharm-1550300435.pdf

PATENT LITIGATION
13 Feb 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090757

FDA
06 Dec 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205784

FDA
12 Jun 2017

http://www.prnewswire.com/news-releases/noden-pharma-notified-of-anda-filing-for-tekturna-300468350.html

PR NEWSWIRE
05 Jun 2017

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205784

FDA
09 Jan 2017

https://www.pharmacompass.com/pdf/news/anchen-pharms-generic-lansoprazole-approved-in-usa-1469863302.pdf

FDA
26 Jul 2016

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty